Myeloma Cure Summit: Definitions, Metrics, and Milestones
A central goal for this meeting is to establish a working consensus on the definition of “cure” in myeloma with international thought leaders on myeloma. Dedicated sessions will evaluate key parameters including depth and durability of minimal residual disease (MRD) negativity, advanced imaging, mass spectrometry, immune reconstitution, time off therapy, restoration of normal function, and potential reversion to an MGUS-like state. These metrics will be discussed under the guidance of leading investigators and clinicians.
Preliminary Program
Thank you to our sponsors:
Educational Workshop in Belgrade, Serbia
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Preliminary Program
Activity Approved by
7th Immune Effector Cell Therapies in Multiple Myeloma Workshop
IMS is pleased to announce that the 7th Annual Immune Effector Cell will take place from March 27-28, 2026 in Boston, MA.
Our sponsors:
Titanium
4th Annual Workshop on Genomics
IMS is pleased to announce that the 4th Annual Workshop on Genomics will take place from July 10-11, 2026 in Warsaw, Poland.
More details will be available soon!
23rd Annual Meeting & Exposition
Mark your calendars for the 23rd IMS Annual Meeting in Glasgow, Scotland.
The International Myeloma Society Annual Meeting is the defining annual meeting in myeloma.
More details on the program, abstract submissions, registration and housing will be available soon.
Our sponsors:
Titanium
Platinum
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
